stella
beta
A Study of Bleeding and Treatment in Participants With Von Willebrand Disease — Stella
Home
/
Von Willebrand Disease (VWD)
/
A Study of Bleeding and Treatment in Participants With Von Willebrand Disease
View on ClinicalTrials.gov
Recruiting
Back to Von Willebrand Disease (VWD) trials
A Study of Bleeding and Treatment in Participants With Von Willebrand Disease
Trial locations
(17 sites)
United States
Phoenix Children's Hospital, Phoenix, Arizona
Arkansas Children's Hospital, Little Rock, Arkansas
Children's Hospital of Los Angeles, Los Angeles, California
University of Miami Hospital and Clinics, Sylvester Comprehensive Cancer Center, Miami, Florida
Emory Children's Center, Atlanta, Georgia
Innovative Hematology, Inc./Indiana Hemophilia and Thrombosis Center, Indianapolis, Indiana
Tulane University School of Medicine, New Orleans, Louisiana
University of Michigan Hospitals, Department of Hemophilia and Coagulation Disorders, Ann Arbor, Michigan
Mayo Clinic - Rochester, Rochester, Minnesota
Oregon Health & Science University, Portland, Oregon
Hemophilia Center of Western Pennsylvania, Pittsburgh, Pennsylvania
The University of Texas Southwestern Medical Center, Dallas, Texas
Washington Institute For Coagulation (WIC), Seattle, Washington
Australia
Fiona Stanley Hospital, Murdoch, Perth
Royal Prince Alfred Hospital, Camperdown, Sydney
The Alfred Hospital, Melbourne, Victoria
United Kingdom
Richmond Pharmacology, London